Table 2.
Contraindications to CHC and contraceptive method use among women Veterans at risk of munintended pregnancy
| Medical Contraindications to CHC | Sample N (%) |
Contraceptive Method Type
|
|||
|---|---|---|---|---|---|
| n (%) using CHC methodsa |
n (%) using Non-CHC prescription methodsb |
n (%) using Non-prescription methodsc |
n (%) using No method |
||
| Total | 1169 (100) | 258 (22.1) | 590 (50.5) | 186 (15.9) | 135 (11.5) |
| No Contraindications | 830 (71.0) | 212 (25.5) | 400 (48.2) | 133 (16.0) | 85 (10.2) |
| Any Contraindication (≥ 1) | 339 (29.0) | 46 (13.6) | 190 (56.1) | 53 (15.6) | 50 (14.8) |
| Hypertension | 174 (14.9) | 25 (14.4) | 90 (51.7) | 28 (16.1) | 31 (17.8) |
| Migraine with aura or migraine >35d | 102 (8.7) | 14 (13.7) | 69 (67.7) | 9 (8.8) | 10 (9.8) |
| Smoker > 35 years old | 86 (7.4) | 11 (12.8) | 46 (53.5) | 13 (15.1) | 16 (18.6) |
| Thromboembolism | 35 (3.0) | 3 (8.6) | 21 (60.0) | 8 (22.9) | 3 (8.6) |
| Stroke | 9 (0.8) | 3 (33.3) | 5 (55.6) | 1 (11.1) | 0 (0) |
| Coronary Artery Disease | 4 (0.3) | 0 (0) | 3 (75.0) | 1 (25.0) | 0 (0) |
| Breast Cancer | 3 (0.3) | 0 (0) | 2 (66.7) | 0 (0) | 1 (33.3) |
CHC, combined hormonal contraception
a
CHC methods: pill, patch, ring.
b
Non-CHC prescription methods: IUD, subdermal implant, injection, male or female sterilization.
c
Non-prescription methods: barrier methods, fertility-awareness, withdrawal.
d
Migraine-related contraindications were determined by presence of ICD-9-CM diagnosis codes in VA administrative data: migraine with aura (346.0, 346.3, 346.5, 346.6) within 10 years prior to the study interview or any migraine (346.xx) within 12 months prior to study interview for women 35 years or older. All other conditions were determined via self-report on the survey instrument.